NSCIF - Nanalysis Scientific Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Nanalysis Scientific Corp.

Bay 1, 4600 5th Street NE
Calgary, AB T2E 7C3
403 769 9499

IndustryScientific & Technical Instruments
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Martin Andrew Burian CPA, CA, CPACorp. Sec. & Independent Chairman11.03kN/A1964
Mr. Sean Krakiwsky M.Sc.Founder, CEO, Pres & Director274.9kN/A1970
Mr. Julien MullerChief Technology Officer158.2kN/AN/A
Mr. Randall McRae C.A., CPACorp. Controller & CFON/AN/AN/A
Dr. Heather PhillipsVP of OperationsN/AN/AN/A
Mr. Matthew SelingerInvestor Relations Mang.N/AN/AN/A
Dr. Susanne RiegelVP of Marketing & Product Mang.N/AN/AN/A
Dr. Greg McFeetorsHead of ManufacturingN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

Corporate Governance

Nanalysis Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.